• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

聚(ADP - 核糖)聚合酶 -1(PARP - 1)作为免疫调节因子。

Poly (ADP-ribose) polymerase-1 (PARP-1) as immune regulator.

作者信息

Laudisi Federica, Sambucci Manolo, Pioli Claudio

机构信息

ENEA (Italian Agency for New Technologies, Energy and Sustainable Economic Development), Laboratory of Radiation Biology and Biomedicine, Rome, Italy.

出版信息

Endocr Metab Immune Disord Drug Targets. 2011 Dec;11(4):326-33. doi: 10.2174/187153011797881184.

DOI:10.2174/187153011797881184
PMID:21476963
Abstract

Poly(ADP-ribose) polymerases (PARPs) represent a family of enzymes which synthesize and bind branched polymers of ADP-ribose to acceptor proteins using NAD as a substrate. PARP-1, the prototypical representative of the family, accounts for the majority of the poly(ADP-ribose) polymer synthesis. PARP-1 functions as a DNA nick sensor and signaling molecule binding to ssDNA and dsDNA protecting cells from genomic instability. PARP-1 activity plays a relevant role in the development of inflammatory responses largely contributing to tissue damage in ischemia/reperfusion conditions, such as stroke and myocardial infarction, and in septic shock. Recently, several findings revealed a wider immunological role for PARP-1. It regulates gene transcription in several types of immune cells, including dendritic cells, macrophages and lymphocytes. PARP-1 affects the stimulatory ability of dendritic cells, T cell activation and antibody production. Inhibition of PARP-1 enzymatic activity reduces the secretion of pro-inflammatory cytokines and ameliorates autoimmune diseases in several experimental models. Our recent findings showed that PARP-1 deficiency affects T cell differentiation rendering naïve CD4 T cells prone to differentiate in regulatory T cells. All together these findings show that PARP-1 plays a pivotal role in the balance between pro-inflammatory/effector and anti-inflammatory/regulatory responses, opening new possible therapeutic perspectives.

摘要

聚(ADP - 核糖)聚合酶(PARPs)是一类酶,它们以NAD为底物,合成并将ADP - 核糖的分支聚合物结合到受体蛋白上。该家族的典型代表PARP - 1负责大部分聚(ADP - 核糖)聚合物的合成。PARP - 1作为一种DNA切口传感器和信号分子,与单链DNA和双链DNA结合,保护细胞免受基因组不稳定的影响。PARP - 1的活性在炎症反应的发展中起相关作用,在很大程度上导致缺血/再灌注条件下的组织损伤,如中风和心肌梗死,以及脓毒症休克。最近,一些研究结果揭示了PARP - 1更广泛的免疫作用。它调节多种免疫细胞类型中的基因转录,包括树突状细胞、巨噬细胞和淋巴细胞。PARP - 1影响树突状细胞的刺激能力、T细胞活化和抗体产生。在几种实验模型中,抑制PARP - 1的酶活性可减少促炎细胞因子的分泌并改善自身免疫性疾病。我们最近的研究结果表明,PARP - 1缺乏会影响T细胞分化,使初始CD4 T细胞易于分化为调节性T细胞。所有这些研究结果表明,PARP - 1在促炎/效应和抗炎/调节反应之间的平衡中起关键作用,开辟了新的可能治疗前景。

相似文献

1
Poly (ADP-ribose) polymerase-1 (PARP-1) as immune regulator.聚(ADP - 核糖)聚合酶 -1(PARP - 1)作为免疫调节因子。
Endocr Metab Immune Disord Drug Targets. 2011 Dec;11(4):326-33. doi: 10.2174/187153011797881184.
2
Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.聚(ADP-核糖)聚合酶(PARP)和 PARP 抑制剂:作用机制及在心血管疾病中的作用。
Cardiovasc Toxicol. 2018 Dec;18(6):493-506. doi: 10.1007/s12012-018-9462-2.
3
The therapeutic potential of poly(ADP-ribose) polymerase inhibitors.聚(ADP - 核糖)聚合酶抑制剂的治疗潜力。
Pharmacol Rev. 2002 Sep;54(3):375-429. doi: 10.1124/pr.54.3.375.
4
Beyond DNA repair, the immunological role of PARP-1 and its siblings.除了 DNA 修复,PARP-1 及其同源物的免疫学作用。
Immunology. 2013 Aug;139(4):428-37. doi: 10.1111/imm.12099.
5
The Role of PARP-1 in Host-Pathogen Interaction and Cellular Stress Responses.PARP-1在宿主-病原体相互作用及细胞应激反应中的作用
Crit Rev Eukaryot Gene Expr. 2015;25(2):175-90. doi: 10.1615/critreveukaryotgeneexpr.2015013626.
6
Structure and function of poly(ADP-ribose) polymerase-1: role in oxidative stress-related pathologies.聚(ADP - 核糖)聚合酶 -1的结构与功能:在氧化应激相关病症中的作用
Curr Vasc Pharmacol. 2005 Jul;3(3):209-14. doi: 10.2174/1570161054368625.
7
Poly(ADP-ribose) polymerase inhibitors: new pharmacological functions and potential clinical implications.聚(ADP-核糖)聚合酶抑制剂:新的药理功能及潜在临床意义
Curr Pharm Des. 2007;13(9):933-62. doi: 10.2174/138161207780414241.
8
PARP inhibitors: new partners in the therapy of cancer and inflammatory diseases.聚(ADP-核糖)聚合酶抑制剂:癌症与炎症性疾病治疗中的新伙伴
Free Radic Biol Med. 2009 Jul 1;47(1):13-26. doi: 10.1016/j.freeradbiomed.2009.04.008. Epub 2009 Apr 10.
9
Poly (adp-ribose) polymerase inhibitors as potential therapeutic agents in stroke and neurotrauma.聚(ADP - 核糖)聚合酶抑制剂作为中风和神经创伤的潜在治疗药物。
Curr Drug Targets CNS Neurol Disord. 2005 Apr;4(2):179-94. doi: 10.2174/1568007053544138.
10
Poly(ADP-ribose) polymerase inhibitors.聚(ADP - 核糖)聚合酶抑制剂
Curr Med Chem. 2003 Feb;10(4):321-40. doi: 10.2174/0929867033368376.

引用本文的文献

1
Modulatory role of vitamins A, B3, C, D, and E on skin health, immunity, microbiome, and diseases.维生素 A、B3、C、D 和 E 对皮肤健康、免疫、微生物组和疾病的调节作用。
Pharmacol Rep. 2023 Oct;75(5):1096-1114. doi: 10.1007/s43440-023-00520-1. Epub 2023 Sep 6.
2
Amazonian fruits with potential effects on COVID-19 by inflammaging modulation: A narrative review.具有调节炎症衰老潜力的亚马逊水果对 COVID-19 的影响:一项叙事性综述。
J Food Biochem. 2022 Dec;46(12):e14472. doi: 10.1111/jfbc.14472. Epub 2022 Oct 14.
3
Enhancing anti-tumour innate immunity by targeting the DNA damage response and pattern recognition receptors in combination with radiotherapy.
通过联合放疗靶向DNA损伤反应和模式识别受体来增强抗肿瘤先天免疫。
Front Oncol. 2022 Aug 29;12:971959. doi: 10.3389/fonc.2022.971959. eCollection 2022.
4
Poly (ADP-ribose) polymerase: An Overview of Mechanistic Approaches and Therapeutic Opportunities in the Management of Stroke.聚(ADP-核糖)聚合酶:在脑卒中管理中机制方法和治疗机会的概述。
Neurochem Res. 2022 Jul;47(7):1830-1852. doi: 10.1007/s11064-022-03595-z. Epub 2022 Apr 18.
5
Discovery of an NAD analogue with enhanced specificity for PARP1.一种对PARP1具有更高特异性的NAD类似物的发现。
Chem Sci. 2022 Jan 27;13(7):1982-1991. doi: 10.1039/d1sc06256e. eCollection 2022 Feb 16.
6
Existing Evidence for the Repurposing of PARP-1 Inhibitors in Rare Demyelinating Diseases.PARP-1抑制剂在罕见脱髓鞘疾病中重新利用的现有证据。
Cancers (Basel). 2022 Jan 29;14(3):687. doi: 10.3390/cancers14030687.
7
The Antiviral Activities of Poly-ADP-Ribose Polymerases.聚 ADP 核糖聚合酶的抗病毒活性。
Viruses. 2021 Mar 30;13(4):582. doi: 10.3390/v13040582.
8
ADP-ribosylation in evasion, promotion and exacerbation of immune responses.ADP-核糖基化在免疫反应的逃避、促进和恶化中的作用。
Immunology. 2021 Sep;164(1):15-30. doi: 10.1111/imm.13332. Epub 2021 Apr 12.
9
Poly(ADP-Ribose) Polymerase Inhibition in Acute Lung Injury. A Reemerging Concept.多聚(ADP-核糖)聚合酶抑制剂在急性肺损伤中的作用:一个重新出现的概念。
Am J Respir Cell Mol Biol. 2020 Nov;63(5):571-590. doi: 10.1165/rcmb.2020-0188TR.
10
The Landscape of Targeted Therapies in TNBC.三阴性乳腺癌的靶向治疗概况
Cancers (Basel). 2020 Apr 8;12(4):916. doi: 10.3390/cancers12040916.